Fig. 2

Nine-class bivariate choropleth map of (A) distributions active buprenorphine prescribers and patient volume, (B) distributions of DATA-waived clinicians and active buprenorphine prescribers, and (C) distributions of DATA-waived clinicians and patient volume in California, 2021.